Landkind Reaches Significant Regulatory Milestone, achieving GRAS Status for LK-01 Pure Salidroside
Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications
DoubleRainbow Biosciences and Landkind to Participate in SupplySide West Conference October 31 - November 4
Double Rainbow Announces Membership with BioMADE
DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics
Landkind launches LK-01 Pure Salidroside for cognitive and athletic performance
Double Rainbow launches Landkind to deliver a new class of sustainable wellness products
Double Rainbow announces $10 million investment from Betta Pharmaceuticals
